Evidence map›Paper›PMID 29393487›Full record

ArticleMolecular medicine reports2018

Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain.

Anqi Ge, Shu Wang, Bei Miao, Ming Yan

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04089813 (Effect of Metformin on Chronic Pain After Thoracic Surgery in Diabetic Patients), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04089813 unknown statusnot on this mapstarted 2019, after this paper: background citation

Effect of Metformin on Chronic Pain After Thoracic Surgery in Diabetic Patients

TypeobservationalSponsorXuzhou Medical UniversityRan2019 to 2020Enrolled200ConditionsPostoperative Chronic PainArmsMetformin
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Review
  15. The changes of nociception and the signal molecules expression in the dorsal root ganglia and the spinal cord after cold water swimming stress in mice.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anqi Ge *Jiangsu Province Key Laboratory of Anesthesiology, Clinic Skill Center, Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China.
Shu Wang *Department of Anesthesiology, The Third People's Hospital, Yancheng, Jiangsu 224001, P.R. China.
Bei MiaoLaboratory of Gastroenterology, Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China.
Ming YanJiangsu Province Key Laboratory of Anesthesiology, Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, P.R. China.
Xuzhou Medical College · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic pain (NP) is a frustrating and burdensome problem. Current treatments for NP have unendurable side effects and/or questionable efficacy, and once these therapies are stopped, the symptoms often return. Thus, novel drugs are needed to enhance the effectiveness of treatments for NP. One novel target for pain treatments is adenosine monophosphate‑activated protein kinase (AMPK), which regulates a variety of cellular processes, including protein translation, which is considered to be affected in NP. Metformin is a widely available drug that possesses the ability to activate AMPK. The signal transducer and activator of transcription 3 (STAT3) pathway plays an important role in neuroinflammation. The present study investigated the analgesic effect of metformin on NP induced by chronic constriction injury (CCI), and the influence of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn (SDH). In CCI rats, paw withdrawal latencies in response to thermal hyperalgesia were significantly shorter, while phosphorylated (p)‑AMPK was expressed at lower levels and p‑STAT3 was expressed at higher levels in the SDH. Administering intraperitoneal injections of metformin (200 mg/kg) for 6 successive days activated AMPK and suppressed the expression of p‑STAT3, in addition to reversing hyperalgesia. Finally, metformin inhibited the activation of microglia and astrocytes in the SDH, which may explain how it alleviates NP.

Indexed as

AMP-Activated Protein KinasesAnimalsAstrocytesBehavior, AnimalBiomarkersBlood GlucoseDisease Models, AnimalFluorescent Antibody TechniqueGene Expression RegulationMaleMetforminMicrogliaNeuralgiaRatsSpinal Cord Dorsal HornSTAT3 Transcription FactorAMP-Activated Protein KinasesBiomarkersBlood GlucoseMetforminSTAT3 Transcription Factoradenosine monophosphate-activated protein kinasegliametforminneuropathic painsignal transducer and activator of transcription 3spinal dorsal horn

Identifiers

PMID29393487
PMCPMC5865989
OpenAlexW2792149531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.